School of Medicine

Millions of Americans suffer from food allergies, and those numbers are quickly rising. Allergic reactions can range from rashes to life-threatening anaphylactic shock. WUSM physician James Wedner reveals a number of details about food allergies in the following St. Louis Post-Dispatch article.

Barnes-Jewish St. Peters Hospital, the Alvin J. Siteman Cancer Center and Washington University School of Medicine proudly announce the opening of the new Siteman Cancer Center at Barnes-Jewish St. Peters Hospital. Together, the three organizations will bring world-class cancer care to St. Charles County.

Below is a link to the Washington University news release about the U.S. News & World Report undergraduate rankings for 2004-05: http://news-info.wustl.edu/news/page/normal/3627.html To view a full listing of U.S. News magazine, book and Web-only rankings for 2004-05, please visit the U.S. News & World Report site: http://www.usnews.com/usnews/edu/college/rankings/rankindex_brief.php

Photo by Robert BostonThe state-of-the-art Farrell Learning and Teaching Center will celebrate its grand opening Sept. 16 with a series of events.

WUSTL pharmacogenetics researchers are using National Institutes of Health funding to find ways to personalize cancer treatments.

Opened to external users in June, the Open Network Laboratory has already registered users from 14 different institutions.

The chimp genome’s remarkable closeness to the human genome will make it a powerful tool for comparative genetics. More medical news

Photo by Robert BostonMedical students Tom Shane and Steve Sperry sample weights at the new student workout center, which they helped organize.

The protein has the ability to help keep cells alive, but does so by interfering with programmed cell death, or apoptosis.

Researchers are trying to reduce the number of pills needed by AIDS patients.The public perception of AIDS treatment — a cocktail of many different pills taken several times a day and sometimes even in the middle of the night — has largely been erased in the United States thanks to advances in drug design and delivery. Although textbook treatment guidelines still call for patients to take a few AIDS medications twice a day, many patients in industrialized countries are now able to keep sufficiently high medication levels in their bodies with once-daily doses. Now researchers in an international collaborative that includes the Aids Clinical Trials Unit (ACTU) at Washington University School of Medicine in St. Louis have begun an ambitious new study to see if this treatment paradigm can be implemented in Third World countries.